Skip to main content
50°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ACAD
Recent news which mentions ACAD
< Previous
1
2
3
4
5
6
7
Next >
Analyst Ratings for ACADIA Pharmaceuticals
April 14, 2023
Tickers
ACAD
Tags
ACAD
Analyst Ratings
Market News
From
Benzinga
Analyst Ratings for ACADIA Pharmaceuticals
March 20, 2023
Tickers
ACAD
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
Tickers
ACAD
ALKS
ARKG
BPMC
Tags
ACAD
IDNA
RXDX
From
InvestorPlace
Acadia Pharmaceuticals Gets Price Target Bumps By Analysts After FDA Approval Of Rett Syndrome Drug
March 14, 2023
Tickers
ACAD
Tags
Market News
PT Changes
Markets
From
Benzinga
Jabil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Tuesday
March 14, 2023
Tickers
ACAD
AMLX
CLBT
ELF
Tags
OPRT
JBL
News
From
Benzinga
Acadia Pharma's Rett Syndrome Drug Becomes First FDA-Approved Treatment
March 13, 2023
Tickers
ACAD
Tags
Benzinga
Health Care
General
From
Benzinga
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
March 13, 2023
Tickers
ACAD
CING
CYTO
CZOO
Tags
OBSV
HYPR
PRVB
From
Benzinga
3 Nasdaq Stocks on Watch This Week
March 12, 2023
Tickers
ACAD
AXSM
ROKU
SIVB
Tags
Recent Press Releases
SIVB
Market News
From
Motley Fool
1 Top Biotech Stock to Buy in March
March 07, 2023
Tickers
ACAD
NEU
Tags
Recent Press Releases
Market News
ACAD
From
Motley Fool
Looking Into ACADIA Pharmaceuticals's Return On Capital Employed
March 02, 2023
Tickers
ACAD
Tags
Benzinga
ACAD
Earnings
From
Benzinga
Analysts See Steady Growth For Acadia Pharma's Nuplazid
February 28, 2023
Tickers
ACAD
Tags
Analyst Ratings
General
Benzinga
From
Benzinga
What 10 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
February 28, 2023
Tickers
ACAD
Tags
BZI/AAR
ACAD
Market News
From
Benzinga
Earnings Scheduled For February 27, 2023
February 27, 2023
Tickers
AAON
ACAD
ACHC
ADUS
Tags
LI
TREX
ICUI
From
Benzinga
Earnings Preview For ACADIA Pharmaceuticals
February 24, 2023
Tickers
ACAD
Tags
Market News
BZI/EP
ACAD
From
Benzinga
Analyst Expectations for ACADIA Pharmaceuticals's Future
January 31, 2023
Tickers
ACAD
Tags
BZI/AAR
ACAD
Analyst Ratings
From
Benzinga
Mizuho Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know
December 21, 2022
Tickers
ACAD
Tags
ACAD
Market News
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Tickers
ACAD
ACDC
AEIS
ANET
Tags
Market News
AUPH
FNKO
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Tickers
ABMD
ACAD
AKTX
AMC
Tags
TROX
VRNS
Market News
From
Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Tickers
ACAD
ADMP
AGEN
ALEC
Tags
Market News
DVAX
BNTX
From
Benzinga
U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review
September 12, 2022
Tickers
ACAD
Tags
Benzinga
Health Care
News
From
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
HRTX
BMY
OBSV
From
Benzinga
ACADIA Pharmaceuticals's Return On Capital Employed Insights
August 29, 2022
Tickers
ACAD
Tags
BZI/ROCE
Market News
ACAD
From
Benzinga
Acadia Terminates Painkiller, Cancer Candidate After Disappointing Data
August 09, 2022
Tickers
ACAD
VRTX
Tags
Benzinga
Health Care
News
From
Benzinga
ACADIA Pharmaceuticals Faces Several Price Target Cuts After Q2 Results, But This Analyst Disagrees
August 09, 2022
Tickers
ACAD
Tags
Benzinga
Analyst Ratings
News
From
Benzinga
NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday
August 09, 2022
Tickers
ACAD
BC
CRSP
MNDY
Tags
News
Price Target Changes
Pre/Market Outlook
From
Benzinga
ACADIA Pharmaceuticals: Q2 Earnings Insights
August 08, 2022
Tickers
ACAD
Tags
Benzinga
BZI/Recaps
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Tickers
ACAD
AZEK
BALL
BCRX
Tags
CTVA
Upgrades
Analyst Ratings
From
Benzinga
8 Analysts Have This to Say About ACADIA Pharmaceuticals
August 05, 2022
Tickers
ACAD
Tags
BZI/AAR
ACAD
Market News
From
Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Tickers
ACAD
AKBA
ALDX
AMRX
Tags
IBB
ATNX
KZIA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Tickers
AAWW
ACAD
ARRY
ATI
Tags
ATI
Downgrades
FOXF
From
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.